+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Digital Neuro Biomarkers Market Size, Share & Trends Analysis Report By Type (Wearable, Mobile Based Applications), By Clinical Practice, By End Use, By Region And Segment Forecasts, 2024 - 2030

  • PDF Icon

    Report

  • 100 Pages
  • August 2024
  • Region: Global
  • Grand View Research
  • ID: 5998742
Description Jump to:

Digital Neuro Biomarkers Market Growth & Trends

The global digital neuro biomarkers market size is anticipated to reach USD 2.82 billion by 2030 and is projected to grow at a CAGR 25.3% from 2024 to 2030. The market is witnessing significant growth owing to various factors such as increased prevalence of neurological disorders, rising geriatric population globally, advances in technology, demand for personalized medicine, and increased investment in the market by private and public players. Furthermore, positive regulatory approvals and increasing reimbursement coverage for digital health technologies encourage the adoption of digital neuro biomarkers. Regulatory bodies are recognizing the potential of these technologies to improve patient outcomes, leading to supportive policies and reimbursement models.

The increasing prevalence of neurological disorders such as Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis is significantly fueling the demand for digital neuro biomarkers. These complex conditions necessitate accurate, continuous monitoring and early detection to manage symptoms effectively and improve patient outcomes. Digital neuro biomarkers, through advanced technologies such as wearable sensors and mobile health applications, offer precise tracking of neurological functions and disease progression. By providing real-time data and insights, these biomarkers enable early intervention and personalized treatment strategies, addressing the critical need for timely and targeted management of neurological conditions. For instance, in the U.S., close to 1 million individuals are impacted by multiple sclerosis (MS). Globally, it is estimated that over 2.8 million people are living with MS, according to the National Multiple Sclerosis Society. While most MS diagnoses occur between the ages of 20 and 50, the condition can affect individuals at any age. In addition, MS is more commonly diagnosed in women compared to men.

There is a growing emphasis on early detection and prevention of neurological diseases. Digital neuro biomarkers offer the advantage of detecting disease markers at an earlier stage than traditional methods, allowing for timely intervention and management. Integration of AI and machine learning is also driving the market growth, for instance, in September 2022, Nutromics secured USD 14 million in funding from Dexcom Ventures to advance its 'lab-in-a-patch' platform. This innovative technology utilizes DNA sensors to monitor a range of targets, including disease biomarkers and challenging-to-dose medications. Moreover, the integration of digital neuro biomarkers with broader digital health platforms, including electronic health records (EHRs) and telemedicine, enhances their utility and accessibility. This integration facilitates continuous monitoring and real-time data analysis, improving patient care and outcomes. For instance, In October 2021, Altoida, Inc., an AI company at developing advanced neurological disease diagnostics, launched a five-year multicenter observational study. This extensive study will involve thousands of patients across all stages of Alzheimer’s disease, aiming to enhance the understanding and diagnostic capabilities of the disease continuum.

Key players are adopting various strategies to maintain a competitive edge such as mergers, acquisition, product launches, etc. Some of the key strategic initiatives by the major market players include:

  • In April 2024, Tris Pharma Inc. entered into a licensing agreement with Braingaze Ltd. and established Tris Digital Health. This new division will focus on the development and distribution of digital diagnostic and therapeutic products for attention-deficit/hyperactivity disorder (ADHD) and other neurological health conditions
  • In March 2024, Cumulus Neuroscience was awarded a grant of nearly USD 1.25 million from the Innovate UK SBRI (Small Business Research Initiative). This funding will support the development and validation of an AI diagnostic tool designed to enhance the accuracy of blood biomarkers. The new AI algorithms will integrate blood biomarkers with digital biomarkers - obtained through the Cumulus Neuroassessment Platform - and demographic information
  • In January 2024, Researchers from the Harvard John A. Paulson School of Engineering and Applied Sciences, Boston University Sargent College of Health & Rehabilitation Sciences, and the Wyss Institute at Harvard University developed a soft, wearable robot designed to assist individuals with Parkinson’s disease in walking more smoothly. This innovative robotic garment, which is worn around the thighs and hips, provides a gentle push to the hips during each leg swing. This support helps the patient achieve a longer stride and reduces instances of freezing, improving mobility and overall walking ability

Digital Neuro Biomarkers Market Report Highlights

  • Based on type, the wearable segment led the market with the largest revenue share of 41.1% in 2023. The mobile-based application segment is expected to witness at the fastest CAGR over the forecast period.
  • Based on clinical practice, the diagnostic segment led the market with the largest revenue share of 32.23% in 2023. The monitoring segment is expected to witness at the fastest CAGR over the forecast period
  • Based on end use, the healthcare companies segment led the market with the largest revenue share of 50.7% in 2023. The healthcare providers segment is expected to witness at the fastest CAGR over the forecast period
  • North America dominated the market with a revenue share of 58.45% in 2023. The rising need for diagnosing neurological disorders has significantly increased the demand for neurological biomarkers

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players worldwide.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Segment Definitions
1.2.1. Type
1.2.2. Clinical Practice
1.2.3. End Use
1.2.4. Regional Scope
1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. Clinical practice outlook
2.2.3. End Use outlook
2.3. Regional outlook
2.4. Competitive Insights
Chapter 3. Digital Neuro Biomarkers Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Digital Neuro Biomarkers Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Environmental landscape
3.3.2.6. Legal landscape
3.3.3. Technology Timeline & Product Pipeline Analysis
3.3.4. Case Study Analysis/ End Use Case Analysis
Chapter 4. Digital Neuro Biomarkers Market: Type Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Digital Neuro Biomarkers Market: Type Movement Analysis
4.3. Digital Neuro Biomarkers Market by Type Outlook (USD Million)
4.4. Wearables
4.4.1. Wearables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Mobile based Applications
4.5.1. Mobile based Applications Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Sensors
4.6.1. Sensors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7. Others
4.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Digital Neuro Biomarkers Market: Clinical Practice Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Digital Neuro Biomarkers Market: Clinical Practice Movement Analysis
5.3. Digital Neuro Biomarkers Market by Clinical Practice Outlook (USD Million)
5.4. Diagnostic Digital Neuro Biomarkers
5.4.1. Diagnostic Digital Neuro Biomarkers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Monitoring Digital Neuro Biomarkers
5.5.1. Monitoring Digital Neuro Biomarkers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Predictive and Prognostic Digital Neuro Biomarkers
5.6.1. Predictive and Prognostic Digital Neuro Biomarkers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Others
5.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Digital Neuro Biomarkers Market: End Use Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Digital Neuro Biomarkers Market: End Use Movement Analysis
6.3. Digital Neuro Biomarkers Market by End Use Outlook (USD Million)
6.4. Healthcare companies
6.4.1. Healthcare companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Healthcare Providers
6.5.1. Healthcare Providers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Payers
6.6.1. Payers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Others
6.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Digital Neuro Biomarkers Market: Regional Estimates & Trend Analysis
7.1. Regional Dashboard
7.2. Regional Digital Neuro Biomarkers Market movement analysis
7.3. Digital Neuro Biomarkers Market: Regional Estimates & Trend Analysis by Type, Clinical Practice & End-use
7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
7.5. North America
7.5.1. North America Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.2. U.S.
7.5.2.1. U.S. Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.3. Canada
7.5.3.1. Canada Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.4. Mexico
7.5.4.1. Mexico Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.5. Europe
7.5.6. Europe Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.7. UK
7.5.7.1. UK Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.8. Germany
7.5.8.1. Germany Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.9. France
7.5.9.1. France Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.10. Italy
7.5.10.1. Italy Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.11. Spain
7.5.11.1. Spain Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.12. Denmark
7.5.12.1. Denmark Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.13. Norway
7.5.13.1. Norway Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.14. Sweden
7.5.14.1. Sweden Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Asia Pacific
7.6.1. Asia Pacific Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.2. Japan
7.6.2.1. Japan Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.3. China
7.6.3.1. China Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.4. India
7.6.4.1. India Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.5. South Korea
7.6.5.1. South Korea Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.6. Australia
7.6.6.1. Australia Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.7. Thailand
7.6.7.1. Thailand Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7. Latin America
7.7.1. Latin America Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7.2. Brazil
7.7.2.1. Brazil Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7.3. Argentina
7.7.3.1. Argentina Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8. Middle East & Africa
7.8.1. Middle East & Africa Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8.2. South Africa
7.8.2.1. South Africa Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8.3. Saudi Arabia
7.8.3.1. Saudi Arabia Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8.4. UAE
7.8.4.1. UAE Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8.5. Kuwait
7.8.5.1. Kuwait Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Market Participant Categorization
8.2. Key Company Profiles
8.2.1. Altoida Inc.
8.2.1.1. Company overview
8.2.1.2. Financial performance
8.2.1.3. Product benchmarking
8.2.1.4. Strategic initiatives
8.2.2. Koneksa
8.2.2.1. Company overview
8.2.2.2. Financial performance
8.2.2.3. Product benchmarking
8.2.2.4. Strategic initiatives
8.2.3. Biogen Inc.
8.2.3.1. Company overview
8.2.3.2. Financial performance
8.2.3.3. Product benchmarking
8.2.3.4. Strategic initiatives
8.2.4. Roche (Navify)
8.2.4.1. Company overview
8.2.4.2. Financial performance
8.2.4.3. Product benchmarking
8.2.4.4. Strategic initiatives
8.2.5. NeuraMetrix
8.2.5.1. Company overview
8.2.5.2. Financial performance
8.2.5.3. Product benchmarking
8.2.5.4. Strategic initiatives
8.2.6. Merck KGaA
8.2.6.1. Company overview
8.2.6.2. Financial performance
8.2.6.3. Product benchmarking
8.2.6.4. Strategic initiatives
8.2.7. Linus Health
8.2.7.1. Company overview
8.2.7.2. Financial performance
8.2.7.3. Product benchmarking
8.2.7.4. Strategic initiatives
8.2.8. Neurotrack Technologies, Inc.
8.2.8.1. Company overview
8.2.8.2. Financial performance
8.2.8.3. Product benchmarking
8.2.8.4. Strategic initiatives
8.2.9. Huma
8.2.9.1. Company overview
8.2.9.2. Financial performance
8.2.9.3. Product benchmarking
8.2.9.4. Strategic initiatives
8.2.10. NeuraLight
8.2.10.1. Company overview
8.2.10.2. Financial performance
8.2.10.3. Product benchmarking
8.2.10.4. Strategic initiatives
List of Tables
Table 1. List of Secondary Sources
Table 2. List of Abbreviations
Table 3. Global digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
Table 4. Global digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
Table 5. Global digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
Table 6. North America digital neuro biomarkers market, by country, 2018 - 2030, (USD Million)
Table 7. North America digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
Table 8. North America digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
Table 9. North America digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
Table 10. U.S. digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
Table 11. U.S. digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
Table 12. U.S. digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
Table 13. Canada digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
Table 14. Canada digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
Table 15. Canada digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
Table 16. Mexico digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
Table 17. Mexico digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
Table 18. Mexico digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
Table 19. Europe digital neuro biomarkers market, by country, 2018 - 2030, (USD Million)
Table 20. Europe digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
Table 21. Europe digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
Table 22. Europe digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
Table 23. UK digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
Table 24. UK digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
Table 25. UK digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
Table 26. Germany digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
Table 27. Germany digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
Table 28. Germany digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
Table 29. France digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
Table 30. France digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
Table 31. France digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
Table 32. Italy digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
Table 33. Italy digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
Table 34. Italy digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
Table 35. Spain digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
Table 36. Spain digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
Table 37. Spain digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
Table 38. Denmark digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
Table 39. Denmark digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
Table 40. Denmark digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
Table 41. Norway digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
Table 42. Norway digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
Table 43. Norway digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
Table 44. Sweden digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
Table 45. Sweden digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
Table 46. Sweden digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
Table 47. Asia Pacific digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
Table 48. Asia Pacific digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
Table 49. Asia Pacific digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
Table 50. China digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
Table 51. China digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
Table 52. China digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
Table 53. Japan digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
Table 54. Japan digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
Table 55. Japan digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
Table 56. India digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
Table 57. India digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
Table 58. India digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
Table 59. Australia digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
Table 60. Australia digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
Table 61. Australia digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
Table 62. South Korea digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
Table 63. South Korea digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
Table 64. South Korea digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
Table 65. Thailand digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
Table 66. Thailand digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
Table 67. Thailand digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
Table 68. Latin America digital neuro biomarkers market, by country, 2018 - 2030, (USD Million)
Table 69. Latin America digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
Table 70. Latin America digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
Table 71. Latin America digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
Table 72. Brazil digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
Table 73. Brazil digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
Table 74. Brazil digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
Table 75. Argentina digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
Table 76. Argentina digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
Table 77. Argentina digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
Table 78. MEA digital neuro biomarkers market, by country, 2018 - 2030, (USD Million)
Table 79. MEA digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
Table 80. MEA digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
Table 81. MEA digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
Table 82. South Africa digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
Table 83. South Africa digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
Table 84. South Africa digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
Table 85. Saudi Arabia digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
Table 86. Saudi Arabia digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
Table 87. Saudi Arabia digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
Table 88. UAE digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
Table 89. UAE digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
Table 90. UAE digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
Table 91. Kuwait digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
Table 92. Kuwait digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
Table 93. Kuwait digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
List of Figures
Fig. 1. Information procurement
Fig. 2. Primary research pattern
Fig. 3. Market research approaches
Fig. 4. Value chain-based sizing & forecasting
Fig. 5. Market formulation & validation
Fig. 6. Digital neuro biomarkers market segmentation
Fig. 7. Market driver analysis (current & future impact)
Fig. 8. Market restraint analysis (current & future impact)
Fig. 9. SWOT analysis, by factor (political & legal, economic and technological)
Fig. 10. Porter’s five forces analysis
Fig. 11. Digital neuro biomarkers market, type outlook key takeaways (USD million)
Fig. 12. Digital neuro biomarkers market: type movement analysis (USD million), 2023 & 2030
Fig. 13. Wearable market revenue estimates and forecasts, 2018 - 2030 (USD million)
Fig. 14. Mobile based applications market revenue estimates and forecasts, 2018 - 2030 (USD million)
Fig. 15. Sensors market revenue estimates and forecasts, 2018 - 2030 (USD million)
Fig. 16. Others market revenue estimates and forecasts, 2018 - 2030 (USD million)
Fig. 17. Digital neuro biomarkers market, clinical practice outlook key takeaways (USD million)
Fig. 18. Digital neuro biomarkers market: clinical practice movement analysis (USD million), 2023 & 2030
Fig. 19. Diagnostic psychiatric digital biomarkers market revenue estimates and forecasts, 2018 - 2030 (USD million)
Fig. 20. Monitoring psychiatric digital biomarkers market revenue estimates and forecasts, 2018 - 2030 (USD million)
Fig. 21. Predictive and prognostic psychiatric digital biomarkers market revenue estimates and forecasts, 2018 - 2030 (USD million)
Fig. 22. Others market revenue estimates and forecasts, 2018 - 2030 (USD million)
Fig. 23. Digital neuro biomarkers market, end use outlook key takeaways (USD million)
Fig. 24. Digital neuro biomarkers market: end use movement analysis (USD million), 2023 & 2030
Fig. 25. Healthcare companies market revenue estimates and forecasts, 2018 - 2030 (USD million)
Fig. 26. Healthcare providers market revenue estimates and forecasts, 2018 - 2030 (USD million)
Fig. 27. Payers market revenue estimates and forecasts, 2018 - 2030 (USD million)
Fig. 28. Others market revenue estimates and forecasts, 2018 - 2030 (USD million)
Fig. 29. Digital neuro biomarkers market: regional key takeaways (USD million)
Fig. 30. Digital neuro biomarkers market: regional outlook, 2023 & 2030, USD million
Fig. 31. North America Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 32. U.S. Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 33. Canada Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 34. Mexico Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 35. Europe Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 36. UK Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 37. Germany Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 38. France Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 39. Spain Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 40. Italy Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 41. Norway Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 42. Denmark Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 43. Sweden Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 44. Asia Pacific Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 45. China Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 46. Japan Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 47. India Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 48. South Korea Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 49. Australia Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 50. Thailand Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 51. Latin America Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 52. Brazil Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 53. Argentina Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 54. Middle East and Africa Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 55. South Africa Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 56. Saudi Arabia Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 57. UAE Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 58. Kuwait Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 59. List of key emerging company’s/technology disruptors/innovators

Companies Mentioned

  • Altoida Inc.
  • Koneksa
  • Biogen Inc.
  • Roche (Navify)
  • NeuraMetrix
  • Merck KGaA
  • Linus Health
  • Neurotrack Technologies, Inc.
  • Huma
  • NeuraLight

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages100
PublishedAugust 2024
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 593.1 Million
Forecasted Market Value ( USD ) by 2030 $ 2820 Million
Compound Annual Growth Rate25.3%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Psychiatric Digital Biomarkers Market Size, Share & Trends Analysis Report By Type (Wearables, Mobile Based Applications, Sensors), By Clinical Practice (Diagnostic, Monitoring, Predictive And Prognostic), By End Use, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Psychiatric Digital Biomarkers Market Size, Share & Trends Analysis Report By Type (Wearables, Mobile Based Applications, Sensors), By Clinical Practice (Diagnostic, Monitoring, Predictive And Prognostic), By End Use, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 100 Pages
  • Global
From
Digital Biomarkers Market Size, Share & Trends Analysis Report By Type (Wearable, Mobile Based Applications), By Clinical Practice, By Therapeutic Area, By End-use (Healthcare Companies), By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Digital Biomarkers Market Size, Share & Trends Analysis Report By Type (Wearable, Mobile Based Applications), By Clinical Practice, By Therapeutic Area, By End-use (Healthcare Companies), By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 150 Pages
  • Global
From
Schizophrenia. Current science and clinical practice. Edition No. 1. World Psychiatric Association - Product Image

Schizophrenia. Current science and clinical practice. Edition No. 1. World Psychiatric Association

  • Book
  • 272 Pages
  • Global
Brain Biomarkers Market by Product, Indication, End-Users, Application - Global Forecast 2025-2030 - Product Image

Brain Biomarkers Market by Product, Indication, End-Users, Application - Global Forecast 2025-2030

  • Report
  • 193 Pages
  • Global
From
Central Nervous System Biomarkers Global Market Report 2024 - Product Image

Central Nervous System Biomarkers Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.